Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
July 25 2024 - 6:30AM
Business Wire
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”),
the manufacturer of a proprietary helium plasma and radiofrequency
platform technology marketed and sold as Renuvion®, today announced
that financial results for the second quarter of fiscal year 2024
will be released after the market closes on Thursday, August
8th.
Management will host a conference call at 5:00 p.m. Eastern Time
on August 8th to discuss the results of the quarter, and to host a
question and answer session. To listen to the call by phone,
interested parties may dial 888-645-4404 (or 862-298-0702 for
international callers) and provide access code 13747529.
Participants should ask for the Apyx Medical Corporation Call. A
live webcast of the call will be accessible via the Investor
Relations section of the Company’s website and via the following
link: Apyx Medical Earnings Webcast
A telephonic replay will be available approximately three hours
after the call ends through the following two weeks. The replay can
be accessed by dialing 877-660-6853 for U.S. callers or
201-612-7415 for international callers and using the replay access
code: 13747529. The webcast will be archived on the Investor
Relations section of the Company’s website.
About Apyx Medical
Corporation:
Apyx Medical Corporation is an advanced energy technology
company with a passion for elevating people’s lives through
innovative products, including its Helium Plasma Platform
Technology products marketed and sold as Renuvion in the cosmetic
surgery market and J-Plasma® in the hospital surgical market.
Renuvion and J-Plasma offer surgeons a unique ability to provide
controlled heat to tissue to achieve their desired results. The
effectiveness of Renuvion and J-Plasma are supported by more than
90 clinical documents. The Company also leverages its deep
expertise and decades of experience in unique waveforms through OEM
agreements with other medical device manufacturers. For further
information about the Company and its products, please refer to the
Apyx Medical Corporation website at www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240725161107/en/
Investor Relations: ICR
Westwicke on behalf of Apyx Medical Corporation Mike Piccinino, CFA
investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Dec 2023 to Dec 2024